期刊文献+

对低危前列腺癌治疗策略的再认识及思考 被引量:3

Reconsideration and Thinking of Therapeutic Strategies in Low-risk Prostate Cancer
下载PDF
导出
摘要 前列腺癌被认为是老年男性中最常见的恶性肿瘤。近年来,PSA筛查技术的广泛使用提高了前列腺癌的检出率。但许多低危的非致命性的前列腺癌患者却承受着过度治疗所带来的毒副反应风险。作者就当前用于减少低危前列腺癌过度治疗的新策略进行描述,如观察等待和主动监测策略,并指出癌症的过度治疗是很普遍的现象。未来需要发展更多的对恶性肿瘤进行最优治疗的策略。 The prostate cancer(Pca) is considered as a most common malignant tumor of older men. In recent years, the ad- vent of widespread PSA screening has increased positive detection rate of PCa. However,many patients with low risk, non --threatening cancer are exposed to the risk of significant side effects from over--treatment. The author describes current new strategies, Watchful Waiting and Active Surveillance,for decreasing the over--treatment of low risk PCa,and points out that the phenomenon of cancer over--treatment is a general one in oneology. More strategies need to be developed for the appropriate treatment of other cancer in future.
作者 熊建萍 石超
出处 《医学与哲学(B)》 2011年第2期25-26,32,共3页 Medicine & Philosophy(B)
关键词 前列腺癌 低危 治疗策略 思考 prostate cancer, low-- risk, treatment, thinking
  • 相关文献

参考文献12

  • 1Jemal A, Siegel R, Xu J Q, et al. Cancer statistics , 2010 CA [J]. Cancer J C 1in,2010,60:277-300.
  • 2Andriol G L , Crawford E D, Grubb R L, et al. Mortality results from a randomized prostate cancer screening trial [J] . N Engl J Med,2009,360(13) : 1310 -1319.
  • 3Schr6der F H, Hugosson J, Roobol M J, et al. Screening and prostate cancer mortality in a randomized European study[J] . N Engl J Med,2009,360(13) :1320- 1328.
  • 4Stattin P, HolmbergE, JohanssonJ E, et al. Outcomes in local- ized prostate caneer: National Prostate Cancer Register of Sweden follow up study[J].J Natl Cancer Inst,2010,102(13):950-]-958.
  • 5Shappley W V 3rd, Kenfield S A, Kasperzyk J L, et al. Prospec tive study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort[J]. J Clin Oncol,2009,27(30):4980-4985.
  • 6Johansson J E, Andren O, Andersson S O,et al. Natural history of early localized prostate cancer[J]. JAMA, 2004,291 (22) : 2713-2719.
  • 7Adolfsson J, Tribukait B, Levitt S, et al. The 20 Yr outcome in patients with well or moderately differentiated prostate cancer diagnosed in the prePgA era: the prognostic value of tumour ploidy and comorbidity[J]. Eur Urol,2007,52(4):1028-1035.
  • 8Sakr W A, Haas G P, Cassin B F,et al. The frequency of carcino ma and intraepithelial neoplasia of the prostate in young male patients[J]. J UroI,1993,150:379-385.
  • 9Klotz L, Zhang L, Lan, A, et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostatecancer[J]. J ClinOncol,2010, 28(1):126-131.
  • 10Hayes J H, Ollendorf D A, Pearson S D, et al. Active surveillance compared with initial treat- ment for men with low-risk prostate cancer: a decision analysis[J]. JAMA, 2010, 304(21): 2373-2380.

同被引文献29

  • 1南勋义,贺大林,王明珠,张越,杨志尚.前列腺癌经去势术加中药治疗后PSA和性激素变化的意义[J].临床泌尿外科杂志,2004,19(12):715-717. 被引量:5
  • 2叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:119
  • 3张秉鸿,郭旻,王庆堂,王亮,南勋义.中药鸦胆子对前列腺癌细胞超微结构及PSA水平的影响[J].西南国防医药,2007,17(4):402-404. 被引量:8
  • 4Kang S H, Kim J U, Imm J Y, et al. The effects of dairy processes and storage on insulin--like growth factor--I (IGF--I) content in milk and in model IGF--I-- fortified dairy products[J]. J Dairy Sci, 2006, 89: 402--409.
  • 5Larnkjaer A, Hoppe C,Molgaard C,et ah The effects of whole milk and infant formula on growth and IGF--I in late infancy[J]. Eur J Clin Nutr, 2009,63 : 956-- 963.
  • 6Rich--Edwards J W,Ganmaa D,Pollak M N,et al. Milk consump- tion and the prepubertal somatotropic axis[J]. Nutr J,2007,6:28.
  • 7Midyett L K, Rogol A D,Van Meter Q L, et al. Recombinant in- sulin- like growth factor (IGF) --I treatment in short children with low IGF--I levels: first--year results from a randomized clinical trial[J]. J Clin Endocrinol Metab, 2010, 95: 611--619.
  • 8Tonella P,Fluck C E, Mullis P E. Insulin--like growth factor-- treatment in primary growth hormone insensitivity: effect of re combinant human IGF--I (rhIGF--I) and rhIGF--I/rhIGF--bind ing protein--3 complex[J]. Horm Res Paediatr, 2010, 73: 140-- 147.
  • 9Fujita T. Insulin resistance and salt--sensitive hypertension in metabolic syndrome[J]. Nephrol Dial Transplant, 2007, 22- 3107.
  • 10Lima G A,Correa L L,Gabrich R,et al. IGF--I, insulin and pros- tate eaneer[J]. Arq Bras Endocrinol Metabol, 2009, 53: 969- 975.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部